Kenyon & Kenyon

Practice Areas | News | Patent | Vault Profile | NALP | ATL

Rating are based on thousands of associate surveys.

Main Office: New York
Participating Offices: New York; Washington, D.C.
Prestige [?]: N/A
Compensation [?]:
Hours worked [?]:
Place to stay [?]:
Lifestyle [?]:
Progression potential [?]:
Diversity commitment [?]:
Pro Bono dedication [?]:
User rating [?]:

Write a comment about this firm and share your views.

Most useful comments (See all comments)

No comments have yet been rated as useful.

Most recent comments (See all comments)

There are no comments.

Ratings principally based on over 6,500 associate surveys (3rd-5th years). See The American Lawyer's 2006 Midlevel Associates Survey.

Firm News

Bloomberg Big Law Business
Kenyon & Kenyon Elects Stephen Colbert's Brother as Managing PartnerBloomberg Big Law BusinessKenyon & Kenyon said on Tuesday that it had elected Edward Colbert as its manager partner — the brother of the new Late Show host Stephen Colbert. A press release from the intellectual property-focused law firm doesn't mention the relation between ...Stephen Colbert's Brother To Helm IP Shop Kenyon & KenyonLaw360 (subscription)all 3 news articles »
Colbert Takes the Stage—As Kenyon & Kenyon Managing PartnerThe American LawyerAs IP-centric firms weather turbulent times, New York's Kenyon & Kenyon has elected the comedian's older brother, Edward Colbert, to lead the firm as managing partner. Colbert, who headed Kenyon's Washington, D.C. office for a decade, began a three …
New York Law Journal (registration)
Kenyon Leader Takes Helm at Time of TransitionNew York Law Journal (registration)Kenyon & Kenyon's new managing partner, Edward Colbert, takes over at a time of partner exits and lower demand for litigation. Colbert acknowledges that changes in patent law have affected his firm's revenue but expects Kenyon to grow by focusing on …
Above the Law
What's Going On At Kenyon & Kenyon?Above the Law“The amount of work in patent litigation in particular is down dramatically, and that's something we all have to deal with,” said Michael Lennon, a senior partner at Kenyon & Kenyon. He said the reduced amount of work is tied to a number of factors …
IP Shops See Partners Depart, Plus More Lateral MovesThe American LawyerFRANK BERNSTEIN, the managing partner of Kenyon & Kenyon's Silicon Valley office, recently left the firm to join Redwood Shores, California-based IP boutique Singularity, according to sibling publication The Recorder, which notes that the move leaves ...
IP law boutique nabs Boston Scientific, CVS attorneysBoston Business Journal (blog)Feisthamel was at CVS for eight years, handling everything from trademark to patent to advertising matters. She has also worked for IP specialist Kenyon & Kenyon LLP and at the U.S. Patent and Trademark Office. “It wasn't so much me looking to leave …
Tinder Clashes With AIDS Healthcare Foundation Over STD BillboardNewsweek“These unprovoked and wholly unsubstantiated accusations are made to irreparably damage Tinder's reputation in an attempt to encourage others to take an HIV test offered by your organization,” wrote Jonathan D. Reichman of the law firm Kenyon & Kenyon ...letter - AIDS Healthcare FoundationAIDS Healthcare Foundationall 83 news articles »
Washington-area appointments and promotions for Sept. 28, 2015Washington PostKenyon & Kenyon of the District appointed Edward Colbert managing partner of the firm. Kilpatrick Townsend & Stockton of the District appointed Poqueen Rivera government relations adviser. Miller & Chevalier of the District appointed Theresa Gee member ...
Novartis Sclerosis Drug Patent Gets Axed In AIA ReviewLaw360 (subscription)“While technology companies have historically used the IPR process to successfully challenge patents, it hasn't been a widely used tool by pharmaceutical companies,” lead counsel Michael Levy of Kenyon & Kenyon said in a statement. “The PTAB's decision ...
Generic drugmakers win order invalidating Novartis MS drug patentReutersMichael Levy of Kenyon & Kenyon, who advised generic drug maker Torrent Pharmaceuticals Ltd, the lead plaintiff in the case, said the decision issued last Thursday was noteworthy because it marked one of the first uses by drug companies of the USPTO's ...
Valid XHTML 1.0 Transitional
Valid CSS!